Kevan Shokat co-founded Rezo Therapeutics and is a UCSF professor and HHMI investigator whose research develops new approaches to drug difficult disease targets.
Kevan Shokat co-founded Rezo Therapeutics and is a UCSF professor and HHMI investigator whose research develops new approaches to drug difficult disease targets.